Showing 19,121 - 19,140 results of 35,269 for search '(( 50 ((a decrease) OR (mean decrease)) ) OR ( e ((point decrease) OR (fold decrease)) ))', query time: 1.25s Refine Results
  1. 19121
  2. 19122
  3. 19123

    The Negative Effects of Increasing Canopy Coverage on Plants by Bonnie Chan (3114120)

    Published 2016
    “…<br> <br> The last observer completed two point surveys: the first point survey consisted of a 50m radius and the second a 5m radius. …”
  4. 19124

    Typical GEM (solid curve) for the shuffleboard task, obtained as zeros of the goal function Eq (2), plotted in the dimensionless (<i>x</i>, <i>v</i>) body state space. by Joby John (245590)

    Published 2016
    “…Also shown are the unit vectors tangent and normal to the GEM, and , near a representative operating point <b>x</b>* (Eqs <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1005118#pcbi.1005118.e019" target="_blank">(5)</a> and <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1005118#pcbi.1005118.e024" target="_blank">(6)</a>): small deviations along do not cause error at the target (i.e., they are <i>goal equivalent</i>), while deviations along do (i.e., they are <i>goal relevant</i>). …”
  5. 19125
  6. 19126

    Fig 3 - by Jonathan de Fallois (6640505)

    Published 2022
    “…<p>a Kaplan-Meier survival analysis regarding composite endpoint (all-cause mortality, decrease of eGFR by >50% and ESKD) ESKD = end stage kidney disease. b Kaplan-Meier survival analysis regarding all-cause mortality end-stage kidney disease. c Kaplan-Meier survival analysis regarding >50% decrease from baseline eGFR. d Kaplan-Meier survival analysis regarding ESKD. e Cubic spline curve analysis reflecting adjusted hazard ratios and UPCR UPCR urine protein creatinine ratio.…”
  7. 19127
  8. 19128

    Heat map of metabolite levels in eflornithine, nifurtimox and NECT toxicity experiments. by Isabel M. Vincent (167717)

    Published 2012
    “…<p>Blue represents a decrease in metabolite intensity, red an increase and yellow represents unchanged levels compared to the levels at the 0 hour time point. …”
  9. 19129
  10. 19130

    Cumulative diversity measures over time. by William C. Nelson (6822452)

    Published 2020
    “…<p>Phylotype richness (A) and the inverse Simpson statistic (B) were calculated cumulatively (<i>i</i>.<i>e</i>., combining data from each time point with all previous timepoints) for each gene or functional gene class (<i>nirK</i> and <i>nirS</i> counts were combined; archaeal and bacterial <i>amoA</i> types were combined). …”
  11. 19131

    BrP-LPA inhibits ATX activity <i>in vivo</i>. by Ioanna Nikitopoulou (438643)

    Published 2013
    “…</b> Plasma concentration of different LPA and <b>E.</b> LPC species at different time points following BrP-LPA i.p administration. …”
  12. 19132

    Spatial pattern of receptor opening. by David M. Santucci (376136)

    Published 2013
    “…(G) The decrease in success probability with distance from the site of release for both synaptic (distance from release site<250 nm) and perisynaptic receptors.…”
  13. 19133

    SarA activates <i>fmtA</i> transcription <i>in vitro</i>. by Yinglu Zhao (309307)

    Published 2013
    “…The substitution of T1G in the proposed transcription start point of the <i>fmtA</i> promoter led to a significant decrease in the transcript (*p = 0.0242) whereas the mutation of the T14 to G in P<sub>fmtA</sub>T14G has the most pronounced effect on the transcription (**p = 0.001). …”
  14. 19134

    The effect of an extra reflection site created by a ring on input pulsatile power (see Materials and Methods section). by Niema M. Pahlevan (346295)

    Published 2014
    “…The control case is the aorta without an extra reflection site and the red line is the pulsatile power of the aorta without any rings (i.e. no extra reflection sites). The pulsatile power can increase or decrease compared to the control case (control is the aorta without the ring), the nature of which depends on the location of the ring. …”
  15. 19135

    Fig 6 - by Leonid Chindelevitch (2142973)

    Published 2021
    “…Each point is the rank of the corresponding feature in one of the classification tasks. …”
  16. 19136

    Gene signature induced by <i>Rank</i> overexpression in the dental epithelium and alveolar bone of <i>Msx2</i><sup>−</sup><sup>/−</sup> mice. by Beatriz Castaneda (488166)

    Published 2013
    “…<p>RT-PCR of total RNA extracted from dental epithelium (a) and alveolar bone (c, e) revealed <i>Rank</i> expression in the epithelium and alveolar bone of <i>Msx2</i><sup>−/− </sup><i>Rank<sup>Tg</sup></i> mice. …”
  17. 19137

    FOXO3 regulates autophagy in NSPCs. by Amanda J. Audesse (6580952)

    Published 2019
    “…(E) Overexpression of wild type or constitutive active FOXO3 increases endogenous LC3 levels as shown by western blot in NSPCs. …”
  18. 19138

    Supplementary file 1_Comparative analysis of lipid metabolism in trophoblast subpopulations in preeclampsia and in vitro hypoxia model.pdf by Ivan Antipenko (22808513)

    Published 2025
    “…In vitro hypoxia modeling in BeWo b30 cells recapitulated the SCT-specific phenotype and identified a potential regulatory mechanism: a fivefold increase in PCSK9 expression (padj = 3.53e−10) and a 1.5-fold decrease in SNX17 (padj = 1.76e−04)—key regulators that limit lipoprotein receptor recycling. …”
  19. 19139

    Table 1_Comparative analysis of lipid metabolism in trophoblast subpopulations in preeclampsia and in vitro hypoxia model.xlsx by Ivan Antipenko (22808513)

    Published 2025
    “…In vitro hypoxia modeling in BeWo b30 cells recapitulated the SCT-specific phenotype and identified a potential regulatory mechanism: a fivefold increase in PCSK9 expression (padj = 3.53e−10) and a 1.5-fold decrease in SNX17 (padj = 1.76e−04)—key regulators that limit lipoprotein receptor recycling. …”
  20. 19140

    Table 2_Comparative analysis of lipid metabolism in trophoblast subpopulations in preeclampsia and in vitro hypoxia model.xlsx by Ivan Antipenko (22808513)

    Published 2025
    “…In vitro hypoxia modeling in BeWo b30 cells recapitulated the SCT-specific phenotype and identified a potential regulatory mechanism: a fivefold increase in PCSK9 expression (padj = 3.53e−10) and a 1.5-fold decrease in SNX17 (padj = 1.76e−04)—key regulators that limit lipoprotein receptor recycling. …”